Medizol (Latanoprost)

Latanoprost is a prostaglandin analog used to lower intraocular pressure in glaucoma and ocular hypertension.

• Open-angle glaucoma: reduces intraocular pressure and slows disease progression.
• Ocular hypertension: lowers pressure to prevent development of glaucoma.
• Normal-tension glaucoma: helps control intraocular pressure when it is within normal range.

• Latanoprost binds to prostaglandin F (FP) receptors in the ciliary muscle, activating a cascade that remodels the extracellular matrix and enhances uveoscleral outflow of aqueous humor, thereby decreasing intraocular pressure.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects

• Eye redness: mild conjunctival hyperemia.
• Increased eyelash growth: longer, thicker lashes.
• Eye irritation: foreign body sensation or mild burning.
• Darkening of iris: gradual increase in pigmentation.
• Blurred vision: transient visual disturbance.
• Dry eye sensation: mild dryness or discomfort.

Serious or Rare Side Effects

• Increased intraocular pressure: paradoxical pressure rise.
• Uveitis: inflammation of the uveal tract.
• Corneal edema: swelling of the cornea.
• Severe allergic reaction: swelling, itching, or rash.
• Vision loss: sudden decrease in visual acuity.
• Persistent eye pain: ongoing discomfort requiring medical attention.

Before using Medizol, consider the following precautions.

• Monitor intraocular pressure: regular eye examinations are essential.
• Assess for ocular infections: avoid use if active infection is present.
• Use with caution in patients with a history of uveitis: may exacerbate inflammation.
• Avoid in patients with known hypersensitivity to prostaglandin analogs.
• Pregnancy and breastfeeding: use only if the potential benefit justifies the potential risk.
• Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid)

• Concurrent use with other prostaglandin analog eye drops: may cause excessive pressure reduction.
• Combination with ocular anesthetic drops: increased risk of ocular irritation.
• Use with systemic carbonic anhydrase inhibitors: may lead to unpredictable intraocular pressure changes.

Moderate Interactions (Monitor Closely)

• Co‑administration with beta‑blocker eye drops: additive pressure‑lowering effect.
• Use with ocular corticosteroids: may diminish the efficacy of latanoprost.
• Concurrent systemic NSAIDs: monitor for altered ocular response.